Sign in

CIK 0001010086

  • Accelerated filer

SIGA TECHNOLOGIES INC

Sign in to watch
Ticker
SIGA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133864870
Phone
+1 212-672-9100
Business address
31 EAST 62ND STREET, NEW YORK, NY, 10065
Former names
SIGA PHARMACEUTICALS INC
  1. 4 Open-market sale Director sold 30,000 shares at $5.70 ($171,000)
  2. 4 Open-market sale VP & Chief Scientific Officer sold 50,000 shares at an average $5.61 ($280,530)
  3. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  5. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  10. 4 Derivatives Options or other derivatives
  11. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
  14. 4 Exercise or conversion Executive VP & CFO acquired 58,965 shares (option exercise)
  15. 4 Shares withheld for taxes Director gave up 105,896 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Executive Officer gave up 287,543 shares (to pay taxes)
  17. 4 Open-market buy Director bought 5,000 shares at $5.58 ($27,900)
  18. 4 Open-market sale VP & Chief Scientific Officer sold 50,000 shares at an average $5.17 ($258,263)
  19. 4 Open-market buy Chief Executive Officer bought 15,000 shares at $5.20 ($78,000)
  20. 4 Open-market buy Director bought 10,000 shares at $5.01 ($50,100)

Page 7 of 25 · 495 filings